MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8,299,134 | $6,827,943 | $6,954,057 | $5,409,825 |
| % Growth | 21.5% | -1.8% | 28.5% | – |
| Cost of Goods Sold | $6,052,849 | $5,259,075 | $5,051,600 | $3,994,414 |
| Gross Profit | $2,246,285 | $1,568,868 | $1,902,457 | $1,415,411 |
| % Margin | 27.1% | 23% | 27.4% | 26.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,086,153 | $1,798,414 | $1,670,363 | $1,679,828 |
| SG&A Expenses | $2,241,515 | $1,960,447 | $1,805,490 | $1,810,787 |
| Sales & Mktg Exp. | $155,362 | $162,033 | $135,127 | $130,959 |
| Other Operating Expenses | $22,872 | $0 | $0 | $75,211 |
| Operating Expenses | $2,264,387 | $1,960,447 | $1,805,490 | $1,885,998 |
| Operating Income | -$18,102 | -$391,579 | $96,967 | -$470,587 |
| % Margin | -0.2% | -5.7% | 1.4% | -8.7% |
| Other Income/Exp. Net | $65,815 | $412,201 | $82,807 | $56,106 |
| Pre-Tax Income | $47,713 | $20,622 | $179,774 | -$414,481 |
| Tax Expense | -$90,478 | -$94,427 | $30,809 | $576,250 |
| Net Income | $148,763 | $115,049 | $148,965 | -$990,731 |
| % Margin | 1.8% | 1.7% | 2.1% | -18.3% |
| EPS | 29.13 | 23.64 | 30.54 | -203.13 |
| % Growth | 23.2% | -22.6% | 115% | – |
| EPS Diluted | 28.52 | 22.27 | 27.23 | -203.13 |
| Weighted Avg Shares Out | 5,107 | 5,166 | 5,471 | 4,877 |
| Weighted Avg Shares Out Dil | 5,852 | 5,167 | 5,471 | 4,877 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $1,111 | $6,072 | $839 |
| Interest Expense | $49,745 | $36,868 | $9,800 | $11,950 |
| Depreciation & Amortization | $290,038 | $252,595 | $184,056 | $126,243 |
| EBITDA | $387,496 | $310,085 | $373,630 | -$276,288 |
| % Margin | 4.7% | 4.5% | 5.4% | -5.1% |